curevac - dofaq.co
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters - 25 Apr 2024
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights ...
CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena - 25 Apr 2024
CureVac initiates H5N1 avian influenza vaccine study ...
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
MD Anderson Cancer Center - 16 Apr 2024
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines ...
CureVac Full Year 2023 Earnings: Misses Expectations
Yahoo Finance - 27 Apr 2024
CureVac Full Year 2023 Earnings: Misses Expectations ...
CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines - PharmaTimes
PharmaTimes - 19 Apr 2024
CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines - PharmaTimes ...
CureVac Names New Chief Business Officer
Contract Pharma - 24 Apr 2024
CureVac Names New Chief Business Officer ...
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News
MarketWatch - 24 Apr 2024
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News ...
CureVac appoints new Chief Business Officer By Investing.com
Investing.com - 24 Apr 2024
CureVac appoints new Chief Business Officer By Investing.com ...
German Federal Patent Court changes its mind on CureVac mRNA patent
JUVE Patent - 19 Dec 2023
German Federal Patent Court changes its mind on CureVac mRNA patent ...
CureVac, Acuitas Reach Deal In COVID Vax Patent Dispute
Law360 - 26 Apr 2024
CureVac, Acuitas Reach Deal In COVID Vax Patent Dispute ...
Amid BioNTech legal fight, CureVac takes a loss as German court invalidates patent
FiercePharma - 19 Dec 2023
Amid BioNTech legal fight, CureVac takes a loss as German court invalidates patent ...
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Yahoo Finance - 24 Apr 2024
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update ...
Earnings call: CureVac details strategic initiatives and clinical progress By Investing.com
Investing.com - 24 Apr 2024
Earnings call: CureVac details strategic initiatives and clinical progress By Investing.com ...
CureVac announces positive Phase II Covid-19 vaccine trial data
Clinical Trials Arena - 09 Jan 2024
CureVac announces positive Phase II Covid-19 vaccine trial data ...
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Yahoo Finance - 24 Apr 2024
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer ...
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with ...
Yahoo Finance - 24 Apr 2024
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with ... ...
CureVac to cut costs in restructuring
Yahoo Finance - 24 Apr 2024
CureVac to cut costs in restructuring ...
CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual ...
Yahoo Finance - 23 Apr 2024
CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual ... ...
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
Yahoo Finance - 18 Apr 2024
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 ...